Monitoring Post-Covid Syndrome From A Workers' Comp Perspective
One result of the pandemic that surprised many in our field last year was the limited impact of COVID-19 treatment on retail pharmacy spend. In compensable cases of severe COVID infection, drug therapy was typically administered in a hospital setting. Less severe cases often did not require extensive prescription medications.
As we reported in the 2020 myMatrixx Drug Trend Report, prescription medications used to treat COVID symptoms and dispensed through retail pharmacies represented ...
Log in to Your Free Account to Read the Rest....
The article you are attempting to read is part of our free Premium Media Services, offering original content for the workers' compensation community. Please log in to view this content. Don't have an account? Registration is quick and free! Click here for free and immediate access to all the Featured News and Experts' Views.
Disclaimer: WorkersCompensation.com publishes independently generated writings from a variety of workers' compensation industry stakeholders. The opinions expressed are solely those of the author and do not necessarily reflect those of WorkersCompensation.com.